| Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study V Golder, R Kandane-Rathnayake, AYB Hoi, M Huq, W Louthrenoo, Y An, ... Arthritis research & therapy 19, 1-11, 2017 | 133 | 2017 |
| Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study V Golder, R Kandane-Rathnayake, M Huq, HT Nim, W Louthrenoo, ... The Lancet Rheumatology 1 (2), e95-e102, 2019 | 94 | 2019 |
| Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort V Golder, R Kandane-Rathnayake, AYB Hoi, M Huq, W Louthrenoo, Y An, ... Arthritis research & therapy 18, 1-9, 2016 | 56 | 2016 |
| Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study D Apostolopoulos, R Kandane-Rathnayake, W Louthrenoo, SF Luo, ... The Lancet Rheumatology 2 (1), e24-e30, 2020 | 55 | 2020 |
| Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study V Golder, R Kandane-Rathnayake, M Huq, W Louthrenoo, SF Luo, ... The Lancet Rheumatology 1 (2), e103-e110, 2019 | 49 | 2019 |
| The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus CC Mok, L Hamijoyo, N Kasitanon, S Chen, K Yamaoka, K Oku, MT Li, ... The Lancet Rheumatology 3 (7), e517-e531, 2021 | 37 | 2021 |
| Development of the Asia Pacific lupus collaboration cohort R Kandane‐Rathnayake, V Golder, W Louthrenoo, SF Luo, YJ Jan Wu, ... International journal of rheumatic diseases 22 (3), 425-433, 2019 | 33 | 2019 |
| ‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study R Kandane-Rathnayake, W Louthrenoo, A Hoi, SF Luo, YJJ Wu, YH Chen, ... Arthritis Research & Therapy 24 (1), 70, 2022 | 25 | 2022 |
| Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study R Kandane-Rathnayake, V Golder, W Louthrenoo, YH Chen, J Cho, ... The Lancet Rheumatology 4 (12), e822-e830, 2022 | 21 | 2022 |
| Physician global assessment international standardisation consensus in systemic lupus erythematosus: the PISCOS study M Piga, E Chessa, EF Morand, MF Ugarte-Gil, M Tektonidou, ... The Lancet Rheumatology 4 (6), e441-e449, 2022 | 21 | 2022 |
| Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study R Kandane-Rathnayake, W Louthrenoo, V Golder, SF Luo, YJJ Wu, ... Rheumatology 60 (11), 5185-5193, 2021 | 18 | 2021 |
| Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus LD Zamora, MTM Collante, SV Navarra International Journal of Rheumatic Diseases 23 (2), 197-202, 2020 | 17 | 2020 |
| Biologic therapies in systemic lupus erythematosus CB Bernal, LD Zamora, SV Navarra International Journal of Rheumatic Diseases 18 (2), 146-153, 2015 | 16 | 2015 |
| COVID‐19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration J Cho, R Kandane‐Rathnayake, W Louthrenoo, A Hoi, V Golder, ... International Journal of Rheumatic Diseases 23 (9), 1255, 2020 | 15 | 2020 |
| Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus R Kandane-Rathnayake, JR Kent, W Louthrenoo, SF Luo, YJJ Wu, ... Lupus 28 (14), 1669-1677, 2019 | 14 | 2019 |
| Lupus education for physicians and patients in a resource-limited setting SV Navarra, LD Zamora, MTM Collante Clinical Rheumatology 39, 697-702, 2020 | 10 | 2020 |
| Patterns of medication use in systemic lupus erythematosus: a multicenter cohort study R Kandane‐Rathnayake, W Louthrenoo, SF Luo, YJJ Wu, YH Chen, ... Arthritis care & research 74 (12), 2033-2041, 2022 | 7 | 2022 |
| Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus … J Cho, L Shen, M Huq, R Kandane-Rathnayake, V Golder, W Louthrenoo, ... The Lancet Rheumatology 5 (10), e584-e593, 2023 | 6 | 2023 |
| Serotonin syndrome masquerading as disease flare in lupus nephritis with end‐stage renal disease RV Navarroza, LD Zamora, SV Navarra International Journal of Rheumatic Diseases 22 (10), 1933-1936, 2019 | 5 | 2019 |
| SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus—an analysis of anti-double-stranded DNA monitoring AL Yeo, R Kandane-Rathnayake, R Koelmeyer, V Golder, W Louthrenoo, ... Rheumatology 63 (2), 525-533, 2024 | 4 | 2024 |
